Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2-Metastatic Breast CancerErica L. Mayer,Yue Ren,Nikhil Wagle,Reshma Mahtani,Cynthia Ma,Angela DeMichele,Massimo Cristofanilli,Jane Meisel,Kathy D. Miller,Trevor Jolly,Elizabeth Riley,Rubina Qamar,Priyanka Sharma,Sonya Reid,Natalie Sinclair,Meredith Faggen,Caroline Block,Naomi Ko,Ann Partridge,Wendy Y. Chen,Michelle K. Demeo,Victoria Attaya,Amanda Okpoebo,Yuan Liu,Eric Gauthier,Harold Burstein,Meredith Regan,Sara TolaneyCANCER RESEARCH（2023）引用 13|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
